1. Home
  2. INM vs FCNCO Comparison

INM vs FCNCO Comparison

Compare INM & FCNCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo InMed Pharmaceuticals Inc.

INM

InMed Pharmaceuticals Inc.

HOLD

Current Price

$1.21

Market Cap

3.7M

Sector

Health Care

ML Signal

HOLD

Logo First Citizens BancShares Inc. 5.625% Non-Cumulative Perpetual Preferred Stock Series C

FCNCO

First Citizens BancShares Inc. 5.625% Non-Cumulative Perpetual Preferred Stock Series C

N/A

Current Price

$21.41

Market Cap

0.0

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
INM
FCNCO
Founded
1981
1898
Country
Canada
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
3.7M
N/A
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
INM
FCNCO
Price
$1.21
$21.41
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
195.0K
23.8K
Earning Date
11-06-2025
10-23-2025
Dividend Yield
N/A
6.17%
EPS Growth
N/A
N/A
EPS
N/A
169.27
Revenue
$4,798,116.00
$8,897,000,000.00
Revenue This Year
N/A
$0.56
Revenue Next Year
N/A
$2.24
P/E Ratio
N/A
$9.80
Revenue Growth
N/A
N/A
52 Week Low
$1.13
$20.57
52 Week High
$8.27
$24.40

Technical Indicators

Market Signals
Indicator
INM
FCNCO
Relative Strength Index (RSI) 39.21 38.34
Support Level $1.20 $20.99
Resistance Level $1.36 $21.55
Average True Range (ATR) 0.11 0.29
MACD 0.01 -0.05
Stochastic Oscillator 9.72 29.79

Price Performance

Historical Comparison
INM
FCNCO

About INM InMed Pharmaceuticals Inc.

InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The Company's operations consist of two operating and reportable segments, the InMed Pharma segment and the BayMedica Commercial segment. The InMed Pharma segment is largely organized around the research and development of small molecule pharmaceuticals drug candidates and the BayMedica Commercial segment is largely organized around manufacturing technologies to produce and commercialize bulk rare cannabinoids for sale as ingredients in the health and wellness industry. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease.

About FCNCO First Citizens BancShares Inc. 5.625% Non-Cumulative Perpetual Preferred Stock Series C

First Citizens BancShares Inc is the bank holding company of First Citizens Bank and Trust Company. The company's segments include the General Bank, the Commercial Bank, SVB Commercial, and Rail. The General Bank segment delivers products and services to consumers and businesses through our extensive network of branches and various digital channels. The Commercial Bank segment provides financial services, including lending, leasing, and advisory, to small and mid-market businesses across various industries. The SVB Commercial provides financial services to innovators, investors, and venture firms. The Rail segment provides tailored leasing and financing for railcars and locomotives across North America. It generates the majority of its revenue from the General Banking segment.

Share on Social Networks: